Washington Post – By Sandra G. Boodman -June 27, 2020 at 10:00 a.m. EDT-
Jeff Sipos wasn’t used to feeling wiped out.
At 31, the California elementary school principal was an endurance athlete in exceptional condition. Even though he had… Continue reading
-On Friday 19 June- over 260 people joined our webinar, in partnership with Lymphoma Action, to hear our panel of UK experts answer some of the most commonly asked questions around COVID-19 and Waldenstrom’s macroglobulinaemia (WM).… Continue reading
SAVE THE DATE
August 27-28, 2020
This virtual experience will be available entirely online.
The 2020 IWMF Virtual Educational Forum is a unique opportunity to come together and learn from medical experts and WM community members around the world –… Continue reading
Meletios A. Dimopoulos, MD, discusses safety results from the randomized phase 3 ASPEN trial of zanubrutinib (Brukinsa) in patients with Waldenström macroglobulinemia.
-June 14/20 Published here: onclive.com-
Meletios A. Dimopoulos, MD, professor and chairman of the Department of Clinical Therapeutics at… Continue reading
In the first head-to-head comparison of Bruton tyrosine kinase (BTK) inhibitors, zanubrutinib demonstrated statistically significant and clinically meaningful advantages in safety and tolerability in patients with Waldenström macroglobulinemia (WM) compared with ibrutinib. Although zanubrutinib yielded a numerically higher response rate… Continue reading
In this video, an international panel of experts sat down with Oncology Learning Network to discuss the 3 Bruton’s tyrosine kinase (BTK) inhibitors active in the treatment of Waldenström macroglobulinemia (WM): ibrutinib, acalabrutinib, and zanubrutinib.
This discussion is moderated by… Continue reading
The new reality with Covid-19 has changed how we are all living. In these unprecedented times, Canadian WM patients have continued to support each other, but are doing it differently. Face to face meetings have allowed us to mingle and… Continue reading
Link to previously recorded meeting now available
Fifty WMers from the Philly WM Support Group enjoyed a lively, engaging and informative conversation with Dr. Jorge Castillo, Clinical Director of the Bing Center for Waldenström’s Macroglobulinemia at Dana-Farber Cancer Institute. They had a… Continue reading
The worldwide coronavirus outbreak, declared a pandemic by the World Health Organization (WHO) on Wednesday, March 11, continues to be of great concern to WM patients and caregivers around the world.
Dr. Castillo with the Dana Farber Cancer Institute… Continue reading